← Leaderboards
Connie Marie Westhoff
University Of Pennsylvania
$2,244,254
Attributed
$5,157,288
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–21$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,157,288 · 3
By mechanism
R01$4,877,514 · 2
K01$279,774 · 1
Top collaborators
- Eric E Bouhassira5 shared
- Xiuli An4 shared
- Cheryl Ann Lobo4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- John Patrick Reilly$3,843,760
- Donald L Siegel$6,766,927
- Dustin Brisson$7,866,339
- Leslie Eric Silberstein$41,598,995
- Eliot Peyster$1,372,484
Others in their field
Top investigators on “Erythrocytes”
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$59,483,299
- Russell E Ware · Duke University$40,659,016
- Stephen Lev Hoffman · Sanaria, Inc.$25,570,898
- Stefan H.i. Kappe · Seattle Children'S Hospital$24,818,069
- Mark Thomas Gladwin · Clinical Center$21,310,832
- Manoj T Duraisingh · Harvard University D/B/A Harvard School Of Public Health$19,622,648
Research focus
ErythrocytesProductionBlood GroupsHematopoietic Stem CellsLaboratoriesNew YorkDesignAntigensBlood TransfusionHematopoieticIn VitroBasic ScienceAntibodiesLifeEngineeringCellsBloodBlood BanksInduced Pluripotent Stem CellErythroblastsGenerationsGeneticBlood Group AntigensReagent
Grant awards (12)
Use of forward Genetic approaches to identify Babesia receptors$710,081
R01 · FY2021 · HL
Use of forward Genetic approaches to identify Babesia receptors$718,981
R01 · FY2020 · HL
Use of forward Genetic approaches to identify Babesia receptors$718,981
R01 · FY2019 · HL
Use of forward Genetic approaches to identify Babesia receptors$697,621
R01 · FY2018 · HL
Clinical Grade Cultured Rare Red Blood Cells as Reagents and Future Transfusion Support$421,129
R01 · FY2018 · HL
Clinical Grade Cultured Rare Red Blood Cells as Reagents and Future Transfusion Support$78,757
R01 · FY2018 · HL
Clinical Grade Cultured Rare Red Blood Cells as Reagents and Future Transfusion Support$502,522
R01 · FY2017 · HL
Clinical Grade Cultured Rare Red Blood Cells as Reagents and Future Transfusion Support$505,092
R01 · FY2016 · HL
Clinical Grade Cultured Rare Red Blood Cells as Reagents and Future Transfusion Support$524,350
R01 · FY2015 · HL
DECIPHERING THE FUNCTION OF THE RH BLOOD GROUP PROTEINS$97,578
K01 · FY2002 · DK
DECIPHERING THE FUNCTION OF THE RH BLOOD GROUP PROTEINS$91,098
K01 · FY2001 · DK
DECIPHERING THE FUNCTION OF THE RH BLOOD GROUP PROTEINS$91,098
K01 · FY2000 · DK